<code id='B7D62B21A2'></code><style id='B7D62B21A2'></style>
    • <acronym id='B7D62B21A2'></acronym>
      <center id='B7D62B21A2'><center id='B7D62B21A2'><tfoot id='B7D62B21A2'></tfoot></center><abbr id='B7D62B21A2'><dir id='B7D62B21A2'><tfoot id='B7D62B21A2'></tfoot><noframes id='B7D62B21A2'>

    • <optgroup id='B7D62B21A2'><strike id='B7D62B21A2'><sup id='B7D62B21A2'></sup></strike><code id='B7D62B21A2'></code></optgroup>
        1. <b id='B7D62B21A2'><label id='B7D62B21A2'><select id='B7D62B21A2'><dt id='B7D62B21A2'><span id='B7D62B21A2'></span></dt></select></label></b><u id='B7D62B21A2'></u>
          <i id='B7D62B21A2'><strike id='B7D62B21A2'><tt id='B7D62B21A2'><pre id='B7D62B21A2'></pre></tt></strike></i>

          explore

          explore

          author:explore    Page View:3237
          Photography of the US department of health and human services in Silver Spring MD
          Manuel Balce Ceneta/AP

          An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products.

          Triple-check your data or we’ll reject your device, the FDA warned.

          advertisement

          The goal of third-party testing is to ensure a device meets the FDA’s standards in a range of areas, including biocompatibility, sterility, and mechanical performance. The agency wrote that it has noticed an uptick in false data submissions in recent years, particularly from facilities based in China and India. In some cases, the facilities will send data copied from previous device submissions.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more
          A biotech analyst on neuroscience, placebo effect, not over
          A biotech analyst on neuroscience, placebo effect, not over

          PaulMatteis(right),in2017withthen-colleaguesSeamusFernandez(farleft)GeoffreyPorges.AlexHogan/STATNEW

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          White House pharmacy plagued with problems, investigation finds

          SamuelCorum/GettyImagesThere’sapharmacyintheWhiteHouse—or,atleast,there’sasignthatsays“Pharmacy,”tho